Skip to main content

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

This content is intended only for US-based healthcare providers, and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company.

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice with the illustration of patient case studies.

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice with the illustration of patient case studies.

Features of this webinar include:

  • Easy navigation by topic
  • Linked access to supporting references
  • Case study assessment questions
  • The ability to follow along and perform specific searches within the transcript

Already registered? Log in here

Register now to access the full interactive webinar

About the expert contributors

Dr. Vivek Subbiah

Dr. Vivek Subbiah is currently Chief of Early-Phase Drug Developments at the Sarah Cannon Research Institute, Nashville, TN, USA.

Read more »

Dr. Alexander Drilon

Dr. Alexander Drilon is the Chief of the Early Drug Development Service and an Associate Attending Physician of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center, New York, USA.  

Read more »

Dr. Michelle Williams

Dr. Michelle D. Williams is a Professor in Anatomical Pathology and Section Chief for Head and Neck Pathology at University of Texas MD Anderson Cancer Centre, USA.

Read more »

Financial disclosure

This content is intended only for US-based healthcare providers, and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company.

Disclaimer

Any information provided and opinions expressed do not necessarily reflect the views of Springer Medizin GmbH. Springer Medizin GmbH and its employees, agents and subcontractors are not responsible or in any way liable for the currency of the information, for any errors, omissions or inaccuracies, or for any consequences arising therefrom. Inclusion or exclusion of any product does not imply its use is either advocated or rejected. Use of trade names is for product identification only and does not imply endorsement. Please consult the latest prescribing information from the manufacturer before issuing prescriptions for any products mentioned.